Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab

被引：16
作者：
Liu, Chun-Yu [1 ,2 ]
Teng, Hao-Wei [1 ,2 ]
Lirng, Jiing-Feng [2 ]
Chiou, Tzeon-Jye [2 ,3 ]
Chen, Po-Min [1 ,2 ]
Hsiao, Liang-Tsai [1 ,2 ]
机构：
[1] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei 112, Taiwan
来源：
LEUKEMIA & LYMPHOMA | 2008年 / 49卷 / 10期
关键词：
D O I：
10.1080/10428190802311375
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2018 / 2021
页数：4
相关论文
共 15 条
  • [1] Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma
    Antonini, Giovanni
    Cox, Maria Cristina
    Montefusco, Enrico
    Ferrari, Antonella
    Conte, Esmeralda
    Morino, Stefania
    Latino, Pamela
    Trasimeni, Guido
    Monarca, Bruno
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2007, 81 (02) : 197 - 199
  • [2] Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up
    Bjoerkholm, M.
    Hagberg, H.
    Holte, H.
    Kvaloy, S.
    Teerenhovi, L.
    Anderson, H.
    Cavallin-Stahl, E.
    Myhre, J.
    Pertovaara, H.
    Oest, A.
    Nilsson, B.
    Oesby, E.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (06) : 1085 - 1089
  • [3] Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
    Boehme, V.
    Zeynalova, S.
    Kloess, M.
    Loeffler, M.
    Kaiser, U.
    Pfreundschuh, M.
    Schmitz, N.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (01) : 149 - 157
  • [4] Central nervous system relapse of systemic non-Hodgkin's lymphoma: Results of treatment based on high-dose methotrexate combination chemotherapy
    Bokstein, F
    Lossos, A
    Lossos, IS
    Siegal, T
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (03) : 587 - 593
  • [5] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier, B
    Lepage, E
    Brière, J
    Herbrecht, R
    Tilly, H
    Bouabdallah, R
    Morel, P
    Van den Neste, E
    Salles, G
    Gaulard, P
    Reyes, F
    Gisselbrecht, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) : 235 - 242
  • [6] Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab
    Feugier, P
    Virion, JM
    Tilly, H
    Haioun, C
    Marit, G
    Macro, M
    Bordessoule, D
    Recher, C
    Blanc, M
    Molina, T
    Lederlin, P
    Coiffier, B
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (01) : 129 - 133
  • [7] Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis
    Hollender, A
    Kvaloy, S
    Lote, K
    Nome, O
    Holte, H
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) : 1762 - 1768
  • [8] Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system
    Jahnke, K
    Thiel, E
    Martus, P
    Schwartz, S
    Korfel, A
    [J]. ANNALS OF HEMATOLOGY, 2006, 85 (01) : 45 - 50
  • [9] Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab
    Pels, H
    Schulz, H
    Manzke, O
    Hom, E
    Thall, A
    Engert, A
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2002, 59 (03) : 213 - 216
  • [10] Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: Experience with two cases and review of the literature
    Pels, H
    Schulz, H
    Schlegel, U
    Engert, A
    [J]. ONKOLOGIE, 2003, 26 (04): : 351 - 354
12